On November 9, Aehr Test saw an Intraday Rise of 8.03% in Regular Trading, trading at $58.015 with turnover of $29.4283 million.
The move followed continued investor focus on the company’s stronger-than-expected first-quarter results, raised full-year revenue outlook, and ongoing progress in AI chip testing orders and deployments.
Previously disclosed results showed adjusted EPS of $0.28 versus market expectations of $0.11, while revenue reached $33.007 million versus expectations of $27.072 million. Backlog stood at $100.9 million as of September 25. The company also highlighted progress with a major AI accelerator customer, including equipment deployment tied to wafer-level burn-in testing, reinforcing AI-related demand as a direct support for the stock.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments